Otero, L. http://orcid.org/0000-0002-8348-4340
Zetola, N.
Campos, M.
Zunt, J.
Bayer, A.
Curisinche, M.
Ochoa, T.
Reyes, M.
Vega, V.
Van der Stuyft, P.
Sterling, TR.
Funding for this research was provided by:
Fogarty International Center (K43TW011137)
Article History
Received: 15 November 2022
Accepted: 30 December 2022
First Online: 24 January 2023
Declarations
:
: This protocol has been approved by the Universidad Peruana Cayetano Heredia Ethics Committee (SIDISI 103161) and the Dirección de Prevención y Control de la Tuberculosis of the Ministry of Health of Peru. An amendment of this protocol was approved in July 2020 for modifications due to COVID-19. The protocol is registered in ClincalTrials.gov (NCT03881228) and the Peruvian Register of Health Research (PRISA, code EI0000000517) Informed consent will be obtained signed on paper from December 2019 to March 2020 through a WhatsApp voice note to the study phone number from August 2021 onwards. Only research team members will access participant information that will be stored in password protected RedCap accounts.
: Consent materials are available from the corresponding author on request.
: The authors declare that they have no competing interests.